Spectrum Technology UK Ltd

SWISS DOLORCLAST “The Gold Standard in radial shockwave therapy”, FDA approved


BENEFITS OF THE SWISS DOLORCLAST “ESWT offers two main advantages over traditional surgical methods: fewer potential complications and a faster return to normal activity.” FDA 2007
For the Patient • No anaesthesia • Non invasive • No medication • No surgery • No need for other therapy • Fast treatment – 15 minutes per session, 3-4 sessions required • Fewer complications • Transient analgesic effect after treatment • Quick recovery • Quick results • Outpatient treatment – no overnight stay • Lower time and financial cost		For the Practitioner • High patient acceptance • Simple procedure • “Gold standard in ESWT” – outstanding product quality • FDA approved • European patent – Dolorclast • Broad range of applications • High return on investment • Low operating costs • Low maintenance • High level product support
	ABOUT >>>BENEFITS >>>RESULTS >>>